Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Nuvation Bio (NUVB) Other Operating Expenses (2024 - 2025)

Nuvation Bio (NUVB) has disclosed Other Operating Expenses for 2 consecutive years, with $9.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Other Operating Expenses rose 31.36% to $9.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $9.3 million, a 97.85% decrease, with the full-year FY2025 number at $9.3 million, down 97.85% from a year prior.
  • Other Operating Expenses was $9.3 million for Q4 2025 at Nuvation Bio, up from $7.1 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $425.1 million in Q2 2024 to a low of $7.1 million in Q4 2024.